UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Parkinson's disease symptoms: The patient's perspective

Movement disorders, 2010-08, Vol.25 (11), p.1646-1651

2010

Volltextzugriff (PDF)

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

The Journal of clinical investigation, 2014-03, Vol.124 (3), p.1340-1349

2014

Volltextzugriff (PDF)

Primary progressive multiple sclerosis developing in the context of young onset Parkinson’s disease

Multiple sclerosis, 2013-01, Vol.19 (1), p.123-125

2013

Volltextzugriff (PDF)

Double lesion MRgFUS treatment of essential tremor targeting the thalamus and posterior sub-thalamic area: preliminary study with two year follow-up

British journal of neurosurgery, 2022-04, Vol.36 (2), p.241-250

2022

Volltextzugriff (PDF)

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

Neurobiology of disease, 2010-10, Vol.40 (1), p.216-221

2010

Volltextzugriff (PDF)

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1375-1386

2021

Volltextzugriff (PDF)

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1363-1374

2021

Volltextzugriff (PDF)

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial

JAMA neurology, 2022-12, Vol.79 (12), p.1232

2022

Volltextzugriff (PDF)

Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease

Neurology, 2016-12, Vol.87 (23), p.2451-2456

2016

Volltextzugriff (PDF)

LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide

Neurology : neuroimmunology & neuroinflammation, 2023-11, Vol.10 (6)

2023

Volltextzugriff (PDF)

P121 A review of the telephone advice service for central and north west london integrated sexual health services

Sexually transmitted infections, 2015-06, Vol.91 (Suppl 1), p.A56-A56

2015

Volltextzugriff (PDF)

Creutzfeldt-Jakob Disease in Ireland: Epidemiological Aspects 1980–2002

European neurology, 2004-01, Vol.51 (3), p.132-137

2004

Volltextzugriff (PDF)

Parkinson’s families project: a UK-wide study of early onset and familial Parkinson’s disease

NPJ Parkinson's Disease, 2024-10, Vol.10 (1), p.188-13, Article 188

2024

Volltextzugriff (PDF)

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo super(11)C-DASB PET study

Neurobiology of disease, 2010-10, Vol.40 (1), p.216-221

2010

Volltextzugriff (PDF)

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo11 C-DASB PET study

Neurobiology of disease, 2010, Vol.40 (1), p.216-221

2010

Volltextzugriff (PDF)

Levodopa use and sleep in patients with dementia with Lewy bodies

Movement disorders, 2009-03, Vol.24 (4), p.609-612

2009

Volltextzugriff (PDF)

Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjögren's syndrome

Rheumatology (Oxford, England), 2009-09, Vol.48 (9), p.1174-1176

2009

Volltextzugriff (PDF)

Atypical Parkinsonism‐Dystonia Syndrome Caused by a Novel DJ1 Mutation

Movement disorders clinical practice (Hoboken, N.J.), 2014-04, Vol.1 (1), p.45-49

2014

Volltextzugriff (PDF)

The "Pulvinar" sign in variant Creutzfeldt-Jakob disease

American journal of roentgenology (1976), 2000-08, Vol.175 (2), p.555-556

2000

Volltextzugriff (PDF)

The treatment of dementia with lewy bodies: the role of levodopa

Molloy, Sophie

2005

Volltextzugriff (PDF)

Atypical Parkinsonism-Dystonia Syndrome Caused by a Novel DJ1 Mutation

Movement disorders clinical practice, 2014, Vol.1 (1), p.45-49

2014

Volltextzugriff (PDF)

Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome

Rheumatology (Oxford, England), 2009, Vol.48 (9), p.1174-1176

2009

Volltextzugriff (PDF)

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD

Mediators of inflammation, 2018-01, Vol.2018 (2018), p.1-20

2018

Volltextzugriff (PDF)

Chemogenetics defines receptor-mediated functions of short chain free fatty acids

Nature chemical biology, 2019-05, Vol.15 (5), p.489-498

2019

Volltextzugriff (PDF)

P-selectin mobility undergoes a sol-gel transition as it diffuses from exocytosis sites into the cell membrane

Nature communications, 2022-05, Vol.13 (1), p.3031-3031, Article 3031

2022

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Parkinson's disease symptoms: The patient's perspective

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

Primary progressive multiple sclerosis developing in the context of young onset Parkinson’s disease

Double lesion MRgFUS treatment of essential tremor targeting the thalamus and posterior sub-thalamic area: preliminary study with two year follow-up

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial

Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease

LGI1 Encephalitis and IgG4-Related Disease: Rare Conditions Collide

P121 A review of the telephone advice service for central and north west london integrated sexual health services

Creutzfeldt-Jakob Disease in Ireland: Epidemiological Aspects 1980–2002

Parkinson’s families project: a UK-wide study of early onset and familial Parkinson’s disease

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo super(11)C-DASB PET study

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo11 C-DASB PET study

Levodopa use and sleep in patients with dementia with Lewy bodies

Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjögren's syndrome

Atypical Parkinsonism‐Dystonia Syndrome Caused by a Novel DJ1 Mutation

The "Pulvinar" sign in variant Creutzfeldt-Jakob disease

The treatment of dementia with lewy bodies: the role of levodopa

Atypical Parkinsonism-Dystonia Syndrome Caused by a Novel DJ1 Mutation

Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD

Chemogenetics defines receptor-mediated functions of short chain free fatty acids

P-selectin mobility undergoes a sol-gel transition as it diffuses from exocytosis sites into the cell membrane

Suchergebnisse filtern